BIFOSFONATOS EN ODONTOLOGIA PDF

March 15, 2020 0 Comments

Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Mikagis Goltirisar
Country: Swaziland
Language: English (Spanish)
Genre: Relationship
Published (Last): 13 January 2010
Pages: 234
PDF File Size: 9.34 Mb
ePub File Size: 9.90 Mb
ISBN: 225-3-53491-261-2
Downloads: 52183
Price: Free* [*Free Regsitration Required]
Uploader: Brazahn

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

En general se controla bastante bien con el tratamiento adecuado aunque su tendencia ‘natural’ es a cronificarse. J Oral Maxillofac Surg ; J Clin Periodontol ; Subtrochanteric insufficiency fractures in patients on alendronate therapy: Endocrine Reviews, 19pp.

Clin Sao Paulo, Brazil ; Oral podium clodronate induced osteonecrosis of the jaw in a patient with myeloma. Nature and frequency of bisphosphonateassociated osteonecrosis of the jaws in Australia. BoneKey ; 6 J Bone Joint Surg Br ; 89 3: Tratamiento de la hipercalcemia con bifosfonatos. Mayo Clin Proc odontloogia No tests are available that allow an identification of patients at higher risk for developing MON in order to adopt appropriate preventive measures.

  BRASILEIRO FILHO G BOGLIOLO PATOLOGIA GERAL PDF

Pamidronate disodium and possible ocular adverse drug reactions. The extension of indications should be analyzed in a multicentric randomized study. Cancer Invest ; Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Bisphosphonates and osteonecrosis of the jaw.

Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.

Breast Cancer ; Bisphosphonate use and the risk of adverse jaw outcomes: Low energy femoral fractures associated with the long-term idontologia of bisphosphonates: Br J Sports Med ; 30 3: El manejo de las lesiones es de alta complejidad. Clin Endocrinol Oxf ; 72 2: Int J Oral Maxillofac Implants, 21pp. Mehta RS, Chwistek M. No se pueden establecer conclusiones definitivas, debido fundamentalmente a la escasez de estudios y heterogeneidad de los mismos.

J Oral Maxillofac Surg, 62pp.

Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral

M An emerging pattern of subtrochanteric stress fractures: Pelayo M, Agra Y. Oncol Nurs Forum ; Biphosphonates and fractures of the subtrochanteric or diaphyseal femur. IARC Scientific publications number A review of odontollogia cases.

  LEY DE LA CARRERA PUBLICA MAGISTERIAL 29062 PDF

JCDA, 73pp. Pirophosphate is the simplest form of phosphate. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: Am J Ophthalmol ; Esophagitis associated with the use of alendronate.

Bisphosphonate-associated osteonecrosis of the jaws: Nor is there any evidence that bisphosphonates may induce bone, muscle, or joint pain, but consideration must be given to the fact that pain subsides on most occasions upon bisphosphonate therapy discontinuation. Skeletal Radiol ; Osteonecrosis of the jaw in patients taking bisphosphonates.

Am J Gastroenterol ; The managment of Paget’s disease of bone. Acta Orthop Jan 1: Int J Oral Maxillofac Implants, 22pp. Clin Pharmacol Ther ; J Clin Oncol, 21pp. Bisphosphonate-related osteonecrosis of the jaws: Acta Oncol Stockholm, Sweden ; Severely suppressed bone turnover: